Genmab Refutes Trade Secret Claims in Complaint by AbbVie

Danish biotech company Genmab says AbbVie has filed a complaint against it in a US district court, alleging a misappropriation of AbbVie’s alleged trade secrets.

• Genmab refutes allegations and will defend the company against the claims
• AbbVie’s alleged trade secrets related to the use of disaccharides to improve the hydrophilicity of drug-linkers in antibody-drug conjugates ADCs in connection with rinatabart sesutecan Rina-S and other ADC pipeline products of ProfoundBio
  • NOTE: In May 2024, *GENMAB COMPLETES ACQUISITION OF PROFOUNDBIO
• Genmab’s collaboration with AbbVie related to epcoritamab will continue unaffected while the lawsuit is pending
• NOTE: In June 2024 AbbVie’s Lymphoma Treatment ...